Imbruvica Archives

Imbruvica

FDA approves treatment for chronic graft versus host disease

August 7, 2017

August 3, 2017 – The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey

Imbruvica

FDA approves treatment for chronic graft versus host disease

Reader Survey

Test Your Knowledge

Wegovy TYK

About

Contact

Podcasts

American Nurse Journal

FDA approves treatment for chronic graft versus host disease

Imbruvica

FDA approves treatment for chronic graft versus host disease

Reader Survey

Test Your Knowledge

Wegovy TYK

NurseLine Newsletter

About

Contact

Podcasts

<img class="rss-widget-icon" style="border:0" width="14" height="14" src="https://www.myamericannurse.com/wp-includes/images/rss.png" alt="RSS" /> American Nurse Journal

FDA approves treatment for chronic graft versus host disease

American Nurse Journal